E-Scopics

E-Scopics is a medical technology company headquartered in France. The company enhances the accessibility, affordability, and ease of use of high-quality ultrasound tools at the point of care. Its agile software platform dematerializes and automates ultrasound imaging technology. The ultrasound-as-a-service products derived from this platform are commercialized through pay-per-use or subscription business models for specific applications. The company's first product, Hepatoscope, leverages quantitative imaging capabilities to help any clinician non-invasively assess liver fibrosis and steatosis (key markers of MASLD-MASH) at the bedside.